Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback